MedTrace Logo

FMT in Inflammatory Bowel Disease

NCT03477032 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-05-29

No results posted yet for this study

Summary

This is a prospective observational cohort study, over 52 weeks, evaluating the the use of faecal microbiota transplantation amongst patients with Inflammatory Bowel Disease and Microscopic Colitis

Conditions

Interventions

BIOLOGICAL

Faecal Microbiota Transplantation

Faeces acquired from a healthy donor

Sponsors & Collaborators

  • St Vincent's Hospital Melbourne

    lead OTHER

Principal Investigators

  • Michael Kamm, MBBS · St Vincent's Hospital Melbourne

  • Emily Wright, MBBS · St Vincent's Hospital Melbourne

  • Chamara Basnayake, MBBS · St Vincent's Hospital Melbourne

  • Amy Hamilton, PhD · St Vincent's Hospital Melbourne

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03477032 on ClinicalTrials.gov